20th International Congress » Cognitive disorders

12:00pm-1:30pm

Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis

G. Rizzo, S. Arcuti, M. Copetti, M. Alessandria, R. Savica, A. Fontana, R. Liguori, G. Logroscino (Bologna, Italy)

12:00pm-1:30pm

Analysis of cognitive disorders of Parkinson’s disease (PD) in the comparative aspect

S. Lukmonov, D. Tolibov, A. Sobirov, F. Yunusov, D. Jalilov, K. Abdukhalimova, A. Kalendarev (Tashkent, Uzbekistan)

12:00pm-1:30pm

Cognitive and behavioral problems in children and adolescents with myoclonus dystonia

M.A. Coenen, H. Eggink, H. van den Berg, J.M. Spikman, M.A. Tijssen (Groningen, Netherlands)

12:00pm-1:30pm

Cognitive deficits in Parkinson’s disease: A preliminary study of neuropsychological profiles

R.J. Giannaula, P.G. Sanz, J.C. Maiques, M.B. Seijas, M.J. González Aguilar, L. Grasso (Buenos Aires, Argentina)

12:00pm-1:30pm

Cognitive development in individuals with mild Parkinsonian signs

S. Lerche, K. Brockmann, I. Wurster, A. Pilotto, U. Sünkel, V. Herbst, B. Brixx, A.K. von Thaler, F. Metzger, G. Eschweiler, W. Maetzler, D. Berg (Tübingen, Germany)

12:00pm-1:30pm

Cognitive profile of Filipino patients with X-linked dystonia parkinsonism

J.E.C. Bautista, R.D.G. Jamora, L.K. Ledesma, L.V. Lee, R.L. Rosales, C.C.E. Diesta, A. Domingo (Quezon City, Philippines)

12:00pm-1:30pm

Comparison of Test Your Memory (TYM) and Montreal Cognitive Assessment (MoCA) measures in Parkinson’s disease

E.J. Henderson, H. Chu, D.M. Gaunt, A.L. Whone, Y. Ben-Shlomo, V. Lyell (Bristol, United Kingdom)

12:00pm-1:30pm

Comparison of the utility of three cognitive scales for MDS Level-I diagnosis of mild cognitive impairment in Parkinson’s disease: MoCA, PD-CRS and ACE-III

R. Fernandez-Bobadilla, J. Pagonabarraga, J.A. Matias-Guiu, S. Martínez-Horta, A. Horta-Barba, J. Marin-Lahoz, J. Perez-Perez, B. Pascual-Sedano, H. Bejr-Kasem, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

12:00pm-1:30pm

Correlation between neuro-behavioral symptoms, cognition and gait in patients with dementia with Lewy bodies (DLB)

B. Tousi, L. Mourany (Cleveland, OH, USA)

12:00pm-1:30pm

Depressive disorders in Parkinson’s disease and Alzheimer’s disease

D. Tolibov, G. Rakhimbaeva (Tashkent, Uzbekistan)

12:00pm-1:30pm

Diagnosis and management of dementia with Lewy bodies: Influence of concomitant cerebrovascular disease

A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russia)

12:00pm-1:30pm

Effects of zonisamide on dementia with Lewy bodies (DLB): A post-hoc analysis of phase 2 study for parkinsonism in DLB patients

M. Murata, M. Nakamura, H. Maruyama (Tokyo, Japan)

12:00pm-1:30pm

FYN expression is associated with regulatory region genetic variation

L.M. Bekris, J.A. Zahratka, Y. Shao, M. Shaw, K. Todd, M. Khrestian, J.B. Leverenz (Cleveland, OH, USA)

12:00pm-1:30pm

Gender differences in DLB: frequency, clinical presentation and treatment

S. Garcia-Ptacek, M.G. Kramberger, D. Aarsland (Huddinge, Sweden)

12:00pm-1:30pm

Levodopa impairs learning in healthy young adults: Implications for Parkinson’s disease

P.A. MacDonald, A. Vo, K.N. Seergobin (London, ON, Canada)

12:00pm-1:30pm

Memory compensation strategies in patients with Parkinson’s disease

C.C. Walton, J.Y.Y. Szeto, L. Mowszowski, S.J.G. Lewis, S.L. Naismith (Sydney, Australia)

12:00pm-1:30pm

MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study

R. Biundo, L. Weis, S. Bostantjopoulou, E. Stefanova, C. Falup-Pecurariu, M.G. Kramberger, G. Geurtsen, A. Antonini, D. Weintraub, D. Aarsland (Venice, Italy)

12:00pm-1:30pm

Modeling dementia with Lewy bodies using patient-derived neurons

D.H. Adamowicz, J. Mertens, D.P. Salmon, D.R. Galasko, S. Roy, F.H. Gage (La Jolla, CA, USA)

12:00pm-1:30pm

Neuropsychological assessment in a cohort of patients with Parkinson’s disease

C. Juri, W. Uslar, H. Farias, M. Vasquez (Santiago, Chile)

12:00pm-1:30pm

Neuropsychology and magnetic resonance correlation in Parkinson´s disease mild cognitive impairment: Case-control study

L.F.R. Vasconcellos, M. Adachi, D. Greca, M. Cruz, A.L. Malak, H. Charchat-Fichman, J.S. Pereira (Rio de Janeiro, Brazil)

12:00pm-1:30pm

Optogenetic silencing of locus coeruleus activity in mice impairs cognitive flexibility in an attentional set-shifting task

K. Janitzky, M. Lippert, A. Engelhorn, J. Tegtmeier, J. Goldschmidt, H.J. Heinze, F.W. Ohl (Magdeburg, Germany)

12:00pm-1:30pm

Parkinson’s disease patients with onset in right side have a worse cognitive prognosis

T. Poliakova, I. Zerr, O. Levin (Belgorod, Russia)

12:00pm-1:30pm

Presenting symptoms and cognitive profile in Lewy body dementia: A series of cases

B. Minafra, G.M.D. Toscano, M. Picascia, R. Zangaglia, N.G. Pozzi, M. Terzaghi, R. Manni, E. Sinforiani, C. Pacchetti (Pavia, Italy)

12:00pm-1:30pm

Prevalence of depression and dementia in Parkinson’s disease

A. Kalendarev, F. Yunusov, G. Rakhimbaeva (Tashkent, Uzbekistan)

12:00pm-1:30pm

Relationship of MDS-UPDRS non-motor symptoms to cognitive functioning in patients with Parkinson’s disease

B.A. Bernard, D. Carns, G.T. Stebbins, J.G. Goldman, C.G. Goetz (Chicago, IL, USA)

12:00pm-1:30pm

Social cognition assessment in progressive supranuclear palsy: The cognitive interface with frontotemporal dementia

E.P.F. Resende, P. Caramelli, F.E.C. Cardoso, H.C. Guimarães, M. Hornberger, M. Bertoux, A.L. Teixeira, L. Cruz de Souza (Belo Horizonte, Brazil)

12:00pm-1:30pm

Study of striatal dopamine transporter function in Alzheimer’s disease with parkinsonism

T. Yamamoto, A. Miyake, K. Ikeda, T. Furuya, T. Mitsufuji, Y. Ito, T. Sasaki, K. Takahashi, N. Tamura, I. Matsunari, A. Nobuo (Iruma-gun, Japan)

12:00pm-1:30pm

The clinical significance of brain microbleed in Alzheimer’s disease patients with Parkinsonian signs

J.Y. Ahn, H.T. Kim (Seoul, Korea)

12:00pm-1:30pm

The evaluation of metabolic differences by using 18F-FDG-PET/CT in demented and non demented Idiophatic Parkinson’s disease patients

S. Altinayar, M. Bakir, Y. Demirtas, Y. Kaplan (Malatya, Turkey)

12:00pm-1:30pm

The patterns of olfactory function in Parksinson’s disease patients with mild cognitive impairment

J.W. Park, H.K. Yoon, M.H. Park, D.Y. Kwon (Ansan, Korea)

12:00pm-1:30pm

Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital

S.C. Cerquera Cleves, S.J. Romero Vanegas, F. Cruz Sanabria, C. Ruiz de Sánchez, F.F. Pretelt Burgos (Bogotá, Colombia)